KMDA
Kamada Ltd
NASDAQ · Biotechnology
$8.21
+0.19 (+2.37%)
Open$8.03
Previous Close$8.02
Day High$8.23
Day Low$8.02
52W High$9.16
52W Low$5.54
Volume—
Avg Volume76.3K
Market Cap473.57M
P/E Ratio23.16
EPS$0.35
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+253.5% upside
Current
$8.21
$8.21
Target
$29.02
$29.02
$25.25
$29.02 avg
$47.24
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 160.07M | 138.21M | 66.34M |
| Net Income | 13.92M | 10.82M | -1,785,693 |
| Profit Margin | 8.7% | 8.3% | -2.7% |
| EBITDA | 13.42M | 11.01M | -2,514,054 |
| Free Cash Flow | — | — | -2,843,002 |
| Rev Growth | +15.8% | +15.8% | +6.0% |
| Debt/Equity | 0.04 | 0.04 | 0.11 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |